Discover Funding Opportunities
Describe what you're looking for in plain language, or browse grants from organizations worldwide.
Project grant for international collaboration within Personalised Medicine (EP PerMed)
The purpose of the grant is to support international collaboration in the European Partnership for Personalised Medicine (EP PerMed), with the aim of promoting the development and implementation of personalised medicine. Sweden, via the Swedish Research Council, is one of the countries taking part in the EP PerMed call 'Personalised Medicine for CARdiovascular, MEtabolic, and KidNey diseases (CARMEN2026)'. This grant supports Swedish researchers participating in international consortia of 3-6 partners from at least 3 participating countries. Applicants must submit parallel applications both to the EP PerMed consortium system and to the Swedish Research Council's Prisma system. The grant covers all project-related costs including salaries, premises, running costs, and depreciation costs over a 3-year period. Swedish participation requires a minimum funding of 1.2 million SEK, with a maximum of 3 million SEK for one Swedish partner or 4.5 million SEK total for two Swedish partners in the same consortium. The application process follows a two-stage procedure with outline applications reviewed first, followed by invited full applications.
Project grant for international collaboration within health research (ERA4Health)
The purpose of the grant is to support international collaboration within Fostering a European Research Area for Health Research (ERA4Health), with the aim of funding transnational research collaborations in the European area within prioritised health areas. Sweden is, via the Swedish Research Council, one of the countries taking part in the call Multi-country Investigator-Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases (Trials4Health 2026). This grant specifically supports Swedish researchers participating in international consortiums conducting investigator-initiated clinical trials in cardiovascular, autoimmune and metabolic diseases. The funding requires Swedish partners to submit parallel applications to the Swedish Research Council while participating in the consortium application to ERA4Health. The grant supports 4-year research projects with comprehensive funding for all project-related costs including salaries, premises, running costs, and depreciation costs.